3 Biopharmaceutical Stocks Bucking the Sell-Off Three biopharma companies may appeal to investors looking for firms that have not been rocked by tariff-inspired turbulence. MarketBeat · Apr 10, 2025
Did pharma sector dodge Trump’s tariffs? The EU's not so sure The fear of a trade war over pharmaceuticals between the EU and the US has been avoided for now, but the European Commission remains on guard, considering further tariff deployments likely. Euronews · Apr 3, 2025
AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market Abbvie made an all-time high after announcing an agreement that puts it in the weight loss market; but that just continues a general uptrend in ABBV stock MarketBeat · Mar 23, 2025
3 Top Dividend Kings to Scoop Up for Passive Income Dividend Kings are good choices for reliable, low-risk investing. Barchart · Feb 27, 2025
These Stocks Missed on Earnings, But Will Rebound Next Quarter Here are three stocks from companies that missed on earnings but have strong support from analysts that makes each stock a solid Buy for the next year MarketBeat · Feb 10, 2025
Is Wall Street Bullish or Bearish on AbbVie Stock? Despite AbbVie's underperformance relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock's future. Barchart · Feb 5, 2025
These 3 Dividend Aristocrats Could Be Your Best Investments This Year Trying to make sense of market uncertainty? These 3 Dividend Aristocrats offer stability, strong yields & growth potential to help you weather 2025’s volatility. Barchart · Feb 1, 2025
Stocks Retreat in Afternoon Trading This afternoon, the S&P 500 Index ($SPX ) (SPY ) is down -0.48%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.71%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up -0.36%. Stocks are moving lower this afternoon, after the Dow Jones Industrials posted an... Barchart · Jan 31, 2025
Stocks Climb on Solid Corporate Earnings Results The S&P 500 Index ($SPX ) (SPY ) today is up +0.67%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.32%. March E-mini S&P futures (ESH25 ) are up by +0.71%, and March E-mini Nasdaq... Barchart · Jan 31, 2025
AbbVie Investors Trigger Trend-Following Signal: Time to Load Up AbbVie is on track to sustain growth in the wake of Humira's patent cliff and the forecasts are too low. Investors can look forward to an upgrade cycle in 2025. MarketBeat · Jan 31, 2025
Stocks Climb on Apple Earnings Results and Benign US Inflation News The S&P 500 Index ($SPX ) (SPY ) today is up +0.45%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.85%. March E-mini S&P futures (ESH25 ) are up by +0.42%, and March E-mini Nasdaq... Barchart · Jan 31, 2025
Stock Index Futures Climb as Apple and Intel Provide a Boost, U.S. PCE Inflation Data in Focus March S&P 500 E-Mini futures (ESH25) are up +0.46%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.73% this morning as solid earnings from Apple and Intel buoyed sentiment, while investors geared up for the release of the Federal Reserve’s first-line inflation gauge. Barchart · Jan 31, 2025
3 Recession-Proof Dividend Stocks To Buy Today Companies with long track records of increasing dividends can be a sound way to generate income in retirement. There's three top companies to look at today. Barchart · Jan 18, 2025
AbbVie's Quarterly Earnings Preview: What You Need to Know Pharma giant AbbVie is gearing up to announce its fourth-quarter results later this month and analysts expect a double-digit drop in earnings. Barchart · Jan 16, 2025
Barchart · Jan 15, 2025 2 Dividend Stocks You Can’t Miss in 2025 These companies are well-established with a solid track record of earnings growth and can cushion your portfolio with stability.
Barchart · Jan 10, 2025 Analyst: Sell ‘Magnificent 7’ Stocks and Buy These 3 Dividend Stocks Instead Analysts at Miramar Capital are advising investors to sell “Magnificent 7” and instead invest in lower-valuation, dividend-paying healthcare stocks.
Barchart · Dec 31, 2024 3 Highest-Yielding Dividend Kings To Buy Today Start your New Year early by exploring high-yield Dividend Kings with decades of growth, top analyst ratings, and attractive yields for long-term investors.
Fortune · Dec 10, 2024 Parkinson's disease symptoms reduced by drug in late-stage trial Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose.
Benzinga · Dec 9, 2024 Check Out What Whales Are Doing With ABBV Financial giants have made a conspicuous bullish move on AbbVie. Our analysis of options history for AbbVie (NYSE:ABBV) revealed 10 unusual trades.
Barchart · Dec 9, 2024 Is AbbVie Stock Underperforming the Dow? AbbVie has underperformed the Dow over the past year, but analysts are moderately optimistic about the stock’s prospects.
Benzinga · Dec 4, 2024 Check Out What Whales Are Doing With ABBV Financial giants have made a conspicuous bullish move on AbbVie. Our analysis of options history for AbbVie (NYSE:ABBV) revealed 13 unusual trades.
AAP · Dec 3, 2024 Pharma giant taken to court after breast implant recall Patients allegedly exposed to a higher cancer risk from 'defective' breast implants that have now been recalled are suing a pharmaceutical firm seeking damages.
Barchart · Dec 3, 2024 Don't Miss the Buying Opportunity in This Dividend King, Says Analyst Leerink believes the recent selloff has made valuations attractive.
Benzinga · Nov 29, 2024 Spotlight on AbbVie: Analyzing the Surge in Options Activity Investors with a lot of money to spend have taken a bearish stance on AbbVie (NYSE:ABBV).
Benzinga · Nov 26, 2024 Alector/AbbVie-Partnered Alzheimer's Drug Disappoints In Mid-Stage Study; Alector Lays Off 17% Of Workforce Alector's AL002 fails in Phase 2 Alzheimer's trial, halting extension study; focus shifts to other programs as workforce is cut by 17%.